<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>10652927286042</udiDi>
    <basicUdiDi>B-10652927286042</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273036B0P</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:52.581Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927286028</udiDi>
    <basicUdiDi>B-10652927286028</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273026F13M</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:51.778Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927285953</udiDi>
    <basicUdiDi>B-10652927285953</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273022B0P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:50.968Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927263791</udiDi>
    <basicUdiDi>B-10652927263791</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273024F13M</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:37.467Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927255505</udiDi>
    <basicUdiDi>B-10652927255505</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273019F13M</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:20.480Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927231295</udiDi>
    <basicUdiDi>B-10652927231295</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO275016F4P</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:13.266Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927227359</udiDi>
    <basicUdiDi>B-10652927227359</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273060A4P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:12.466Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927227335</udiDi>
    <basicUdiDi>B-10652927227335</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273026F4P</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:11.663Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927216001</udiDi>
    <basicUdiDi>B-10652927216001</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO274019F13M</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:16:04.463Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927205111</udiDi>
    <basicUdiDi>B-10652927205111</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO274019F4P</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:15:58.857Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927205104</udiDi>
    <basicUdiDi>B-10652927205104</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273019F4P</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:15:58.073Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927205081</udiDi>
    <basicUdiDi>B-10652927205081</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273024F4P</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:15:57.512Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927200222</udiDi>
    <basicUdiDi>B-10652927200222</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273060A2P</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:15:56.456Z</lastUpdated>
  </row>
  <row>
    <udiDi>08698147924703</udiDi>
    <basicUdiDi>8698147S100T0UH</basicUdiDi>
    <tradeName>TEKMON</tradeName>
    <deviceName>TEKMON</deviceName>
    <manufacturerName>DOĞSAN TIBBİ MALZEME SANAYİ A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000016026</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>T3200</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:57:21.385Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927239789</udiDi>
    <basicUdiDi>B-10652927239789</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO175016F13M</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:50.458Z</lastUpdated>
  </row>
  <row>
    <udiDi>08698147924697</udiDi>
    <basicUdiDi>8698147S100T0UH</basicUdiDi>
    <tradeName>TEKMON</tradeName>
    <deviceName>TEKMON</deviceName>
    <manufacturerName>DOĞSAN TIBBİ MALZEME SANAYİ A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000016026</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>T3165</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:46:04.366Z</lastUpdated>
  </row>
  <row>
    <udiDi>18033439444465</udiDi>
    <basicUdiDi>8033439MONOFIL3T</basicUdiDi>
    <tradeName>MONOFIL</tradeName>
    <deviceName>MONOFIL</deviceName>
    <manufacturerName>ASSUT EUROPE SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000018178</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FR458FAT</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:40:07.062Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927779360</udiDi>
    <basicUdiDi>B-10652927779360</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO176013B0P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:45:49.151Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927727453</udiDi>
    <basicUdiDi>B-10652927727453</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO280037B6P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:44:48.258Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927725855</udiDi>
    <basicUdiDi>B-10652927725855</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO272019F4P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:44:37.846Z</lastUpdated>
  </row>
</eudamedExport>